Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MESA LABORATORIES INC /CO/MLAB · Entity 5221 | Director | September 14, 2023 | September 19, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MESA LABORATORIES INC /CO/
Report date September 14, 2023 · Filed September 19, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,760 |
Ending reported balance
After 2023-09-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2023-09-14 · Sale · Disposed 3,000 · Balance 63,760 F1: Mr. Schmieder is no longer a director of the Company effective August 25, 2023 F2: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023 Row 2 · 2023-09-15 · Sale · Disposed 1,000 · Balance 62,760 F2: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023 |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Schmieder is no longer a director of the Company effective August 25, 2023
F2: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2023 Filed Sep 19, 2023 16:34 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,000 | $123.74 | $123,740.00 |
DisclosureSEC source: 0001228924-23-000038 · primary_doc.xml · nonDerivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,760 F2 · kind: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023 Read SEC document |
| September 14, 2023 Filed Sep 19, 2023 16:34 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,000 | $123.05 | $369,150.00 |
DisclosureSEC source: 0001228924-23-000038 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,760 F1 · kind: Mr. Schmieder is no longer a director of the Company effective August 25, 2023 F2 · kind: Sale of securities under a 10b5-1 trading plan implemented June 14, 2023 Read SEC document |
| September 13, 2023 Filed Sep 14, 2023 17:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 3,000 | $123.32 | $369,965.10 |
DisclosureSEC source: 0001228924-23-000036 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,760 F1 · security: Mr. Schmieder is no long a director of the Company effective August 25, 2023 F2 · kind: Sale of securities effected under a 10b5-1 trading plan implemented June 14, 2023 Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 19:19 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 7 · Derivative | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000022 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 754 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs the vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2023 Filed Aug 16, 2023 19:19 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000022 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000012 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next 4 anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 23:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-23-000012 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,006 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 17:33 UTC Amendment | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,571 | $191.31 | $300,548.01 |
DisclosureSEC source: 0001228924-23-000002 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,976 F1 · shares: Sale reported on this Form 4 (and the previous version filed on January 17, 2023) was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2022. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 15:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $122.66 | $0.00 |
DisclosureSEC source: 0001228924-23-000001 · primary_doc.xml · derivative · entry 5 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450 Underlying: Common Stock · 1,000 shares Expires 2023-04-03 F2 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04/03/2017 grant date Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 15:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Options · Derivative | 571 | $0.00 Strike: $72.02 | $0.00 |
DisclosureSEC source: 0001228924-23-000001 · primary_doc.xml · derivative · entry 4 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450 Underlying: Common Stock · 571 shares Expires 2023-04-08 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 04/08/2015 grant date Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 15:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,571 | $191.31 | $300,548.01 |
DisclosureSEC source: 0001228924-23-000001 · primary_doc.xml · nonDerivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,976 Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 15:52 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherCommon Stock | 571 | $72.02 | $41,123.42 |
DisclosureSEC source: 0001228924-23-000001 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,547 Read SEC document |
| November 11, 2022 Filed Nov 21, 2022 15:06 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 2,500 | $175.45 | $438,625.00 |
DisclosureSEC source: 0001228924-22-000042 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,976 F1 · shares: Sale reported on Form 4 was effected pursuant to a Rule 10b%-1 trading plan, adopted by the reporting person on August 16, 2022 Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:43 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 6 · Derivative | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000037 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 431 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Vested RSUs for Board of Directors services F3 · derivative.expiration_date: Not applicable Read SEC document |
| September 01, 2022 Filed Sep 2, 2022 16:43 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000037 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2022 Filed Aug 18, 2022 20:10 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantCommon Stock · Derivative | 754 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000032 · primary_doc.xml · derivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 754 Underlying: Common Stock · 754 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2023 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000011 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2022 Filed Jun 16, 2022 21:47 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000011 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 16:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,000 | $0.00 Strike: $97.78 | $0.00 |
DisclosureSEC source: 0001228924-22-000001 · primary_doc.xml · derivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,021 Underlying: Common Stock · 1,000 shares Expires 2022-04-01 F1 · derivative.exercise_date: 1/5 exercisable on each anniversary date of the 04/01/2016 grant date Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 16:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,000 | $327.77 | $327,770.00 |
DisclosureSEC source: 0001228924-22-000001 · primary_doc.xml · nonDerivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,015 F2 · shares: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2021 Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 16:12 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,000 | $97.78 | $97,780.00 |
DisclosureSEC source: 0001228924-22-000001 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2021 Filed Feb 15, 2022 18:58 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherCommon Stock | 19,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-22-000002 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 19,360 F1 · kind: voluntary filing F2 · ownership.nature: Represents shares owned in an irrevocable trust Read SEC document |
| September 01, 2021 Filed Sep 1, 2021 21:46 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 6 · Derivative | 431 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000065 · primary_doc.xml · derivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 431 Underlying: Common Stock · 431 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on September 1, 2022 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2021 Filed Aug 16, 2021 18:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 5 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000056 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested 100% on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| August 15, 2021 Filed Aug 16, 2021 18:18 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000056 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 11, 2021 Filed Aug 12, 2021 16:16 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 800 | $278.06 | $222,448.00 |
DisclosureSEC source: 0001228924-21-000050 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,707 F1 · shares: Sale reported on this Form 4 was effected pursuant to a 10b5-1 Trading Plan, adopted by the reporting person on June 14, 2021 Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 17:01 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 505 | $262.27 | $132,446.35 |
DisclosureSEC source: 0001228924-21-000042 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,507 F1 · shares: Sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan, adopted by the reporting person on August 15, 2020 Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 4 · Derivative | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000028 · primary_doc.xml · derivative · entry 4 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 265 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's F4 · derivative.exercise_date: Represents Restricted Stock Units granted for the conversion of cash compensation for Board of Director services for the twelve months ended June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000028 · primary_doc.xml · derivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000028 · primary_doc.xml · nonDerivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 17:40 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-21-000028 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 00:24 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,750 | $278.23 | $486,902.50 |
DisclosureSEC source: 0001228924-21-000006 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,717 F1 · shares: Sale reported on Form 4 was effected pursuant to a Rule 10B5-1 trading plan adopted by reporting person on 12-9-20 Read SEC document |
| January 12, 2021 Filed Jan 12, 2021 15:27 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 477 | $285.23 | $136,054.71 |
DisclosureSEC source: 0001228924-21-000004 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,467 F1 · kind: Sale reported on Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2020 Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 15:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 3 · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000033 · primary_doc.xml · derivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 477 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F4 · derivative.exercise_date: RSUs that vested on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 15:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Unit - 5 · Derivative | 308 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000033 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308 Underlying: Common Stock · 308 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on August 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 15, 2020 Filed Nov 16, 2020 15:56 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000033 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: Represents stock from RSUs that vested on November 15, 2020 Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 20:32 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherNon Qualified Stock Option · Derivative | 1,429 | $0.00 Strike: $89.70 | $0.00 |
DisclosureSEC source: 0001437749-20-018051 · rdgdoc.xml · derivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,021 Underlying: Common Stock · 1,429 shares Expires 2023-04-08 F1 · derivative.exercise_date: 1/7 exercisable on each anniversary date of the 4/08/16 grant date Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 20:32 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,429 | $246.29 | $351,948.41 |
DisclosureSEC source: 0001437749-20-018051 · rdgdoc.xml · nonDerivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,467 Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 20:32 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 1,429 | $72.02 | $102,916.58 |
DisclosureSEC source: 0001437749-20-018051 · rdgdoc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 4 · Derivative | 265 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000012 · primary_doc.xml · derivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265 Underlying: Common Stock · 265 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F4 · shares: Represents RSUs granted for the conversion of cash compensation for Board of Directors services for the next 12 months F5 · derivative.exercise_date: Restricted Stock Units that cliff vest on June 15, 2021 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000012 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted Stock Units that vest 1/5 on June 15, 2019 and each of the next four anniversary dates F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2020 Filed Jun 16, 2020 23:09 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000012 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2020 Filed Feb 19, 2020 22:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 1,800 | $266.46 | $479,628.00 |
DisclosureSEC source: 0001228924-20-000003 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,437 Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:53 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | OtherCommon Stock | 118 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-20-000002 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,237 F1 · kind: 118 shares received as a gift Read SEC document |
| November 25, 2019 Filed Nov 26, 2019 21:32 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | SaleCommon Stock | 700 | $238.06 | $166,642.00 |
DisclosureSEC source: 0001228924-19-000053 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,119 Read SEC document |
| November 15, 2019 Filed Nov 18, 2019 21:42 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | GrantRestricted Stock Units - 3 · Derivative | 477 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000048 · primary_doc.xml · derivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 477 Underlying: Common Stock · 477 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vest on November 15, 2020 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 16:51 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Units - 2 · Derivative | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000041 · primary_doc.xml · derivative · entry 2 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: RSUs that vested on November 7, 2019 F3 · derivative.expiration_date: Not Applicable Read SEC document |
| November 07, 2019 Filed Nov 7, 2019 16:51 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 150 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000041 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,819 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · kind: Represents stock from RSUs that vested on November 7, 2019. No shares were sold by the reporting person in connection with this transaction. Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 17:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionRestricted Stock Unit - 1 · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000024 · primary_doc.xml · derivative · entry 3 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120 Underlying: Common Stock · 30 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock F2 · derivative.exercise_date: Restricted stock units that vest 1/5 on June 15, 2019 and each of the next four June 15's thereafter F3 · derivative.expiration_date: Not Applicable Read SEC document |
| June 15, 2019 Filed Jun 17, 2019 17:20 UTC | MESA LABORATORIES INC /CO/ MLAB · Entity 5221 | Exercise / conversionCommon Stock | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001228924-19-000024 · primary_doc.xml · nonDerivative · entry 1 Schmieder John Bradley · CIK 0001637852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.